IVDs May Lose IDE Exemption Under BIMO Reengineering Reg Changes
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of in vitro diagnostic device clinical trials would be required to obtain investigational device exemptions from FDA under a regulation change currently being considered by the agency's bioresearch monitoring (BIMO) reengineering team.